Singapore’s Temasek Holdings had a challenging fiscal year 2018-2019 compounded by trade tensions between the United States and China and a troubled life sciences portfolio. The Singaporean public investor generated a one-year total shareholder return of 1.49% for the period ended March 31, 2019. “We remain watchful around the risks of a late cycle recession […]